Skip to main content
Premium Trial:

Request an Annual Quote

BioTools and Varian to Develop New Magnetic Resonance Diagnostic Tool

Premium

EDMONTON, Alberta--BioTools and Varian have agreed to develop a new magnetic resonance diagnostic tool over the course of an expected three-year project. The effort will involve the clinical application of nuclear magnetic resonance spectroscopy and advanced computational tools such as pattern recognition to the diagnosis and monitoring of disease and health. It also has potential applications in drug and toxicity testing.

The goal of the project is to provide clinicians with an alternative to existing diagnostic instruments that is capable also of recording and interpreting complex biochemical profiles found in biological fluids.

Using pattern recognition methods and specialized databases specific to individual disease states, this application of MRD technology should reveal large amounts of information in a single test sample, ultimately enabling clinicians to more accurately diagnose disease states such as renal disease and cancer, among others.

Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.